QHSLab, Inc. (USAQ): Cost of Revenue
$880.9K
Year ended 2025-12-31
$974.6K
Trailing 12 months to 2026-06-30
+12.2%
3-year compound annual growth
+63.9%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $880.9K | +13.8% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $774.0K | +25.8% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $615.4K | -1.3% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $623.7K | -16.1% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $743.7K | +899.0% | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | $74.4K | n/a | 2022-04-01, From 2020-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| QHSLab, Inc. (USAQ) | 2025-12-31 | $880.9K | +13.8% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $2.31M | -14.9% |
| Femasys Inc (FEMY) | 2025-12-31 | $872.4K | +60.1% |
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $1.10M | +261.8% |
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $2.15M | +17.0% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $302.3K | +81.2% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $1.59M | +1.3% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $2.17M | +19.9% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $1.13M | n/a |
Compare USAQ, OSRH, FEMY, AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗